Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-02-25

FDA Approved: EDARBI — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved EDARBI (azilsartan medoxomil) under the original NDA from Azurity Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Edarbi (azilsartan medoxomil)

Snippet

ORIG AP for EDARBI (AZILSARTAN KAMEDOXOMIL)